| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.36B | $5.34B | $5.34B |
| YoY Revenue Growth % | +0.3% | 0.0% | — |
| Gross Profit | $1.72B | $1.76B | — |
| Gross Margin % | 32.1% | 33.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $181.0M | -$361.0M | $398.0M |
| Operating Margin % | 3.4% | -6.8% | 7.5% |
| Net Income (GAAP) | -$113.0M | -$751.0M | -$77.0M |
| EBITDA (Normalized) | $778.6M | $191.8M | $590.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $943.0M | $703.0M | $796.0M |
| Capital Expenditures (CapEx) | $747.0M | $691.0M | $240.4M |
| Free Cash Flow (FCF) | $196.0M | $12.0M | $555.6M |
| FCF Margin % | 3.7% | 0.2% | 10.4% |
| Return on Invested Capital (ROIC %) | 1.2% | -2.1% | 8.1% |
| Cash & Short-Term Equivalents | — | $173.0M | — |
| Total Debt (Short + Long Term) | $6.11B | $4.91B | $1.50B |
| Total Stockholders' Equity | $8.25B | $8.64B | $3.08B |